Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GETGOAL-S: Lixisenatide add-on to Sulfonylurea in T2DM
NCT00713830Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2008
- Primary completion
- Jan 2011
- Modality
- Peptides
- Countries
- 16
01
Overview
A Phase 3 trial of lixisenatide in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Jul 2008; status: completed.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00713830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00713830.